Researchers at Rush University in Chicago monitored nearly 3,000 people in their 70s who did not have the disease for six years, a third of whom were taking statins. At the end of the study, 53 per cent of those who did not take the drugs developed Parkinsons, compared to just 45 per cent among statins-users. Pictured: stock of statins